Italy's research-based drugmakers' association, Farmindustria, has expressed concern over the negative impact of government measures taken in the wake of the earthquake in Abruzzo in April. The group expressed its appreciation for most of the emergency management covering the area around L'Aquila.
However, the Farmindustria notes that 27% of the region's exports previously came from the drug industry which has worked hard to restore production to damaged facilities. In this context, the pharmaceutical manufacturers' association argues that the cancellation of a government deal to invest in innovative drugs and the levy of an emergency tax to pay for reconstruction in the Abruzzo region are unhelpful.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze